FDA Drug Recalls

Recalls / Class II

Class IID-0016-2021

Product

Ranitidine 150 mg, a) 60 Tabs (NDC 61919-339-60); and b) 90 Tabs (NDC 61919-339-90) bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534

Affected lot / code info
Lots: a) 09AU1911 Exp. 02/28/2022; b) 09SE1904 Exp. 03/31/2022

Why it was recalled

CGMP Deviations: Presence of NDMA impurity detected in product.

Recalling firm

Firm
Direct Rx
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
94 Worldwide Dr, N/A, Dawsonville, Georgia 30534-6828

Distribution

Quantity
a) 54 bottles; b) 26 bottles
Distribution pattern
FL, GA

Timeline

Recall initiated
2020-01-15
FDA classified
2020-10-05
Posted by FDA
2020-10-14
Terminated
2020-12-07
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0016-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.